Introduction
An essential function of the adipose tissue is to secrete adipokines, a group of hormones with effects on whole body metabolism. Adipokines are potentially important for development of obesity-related diseases like diabetes, cardiovascular diseases and cancer (1) . Insulin resistance is a hallmark of diabetes, and its development may involve several adipokines including leptin (2) , tumor necrosis factor (TNF) (3), interleukin (IL)-6 (4), adiponectin (5) and resistin (6) .
The resistin gene belongs to the resistin-like molecules (RELM) gene family (6) (7) (8) . In mice, resistin is preferentially expressed in adipose tissue (6, 7) , whereas RELM is mostly found in adipose tissue and lung (7, 8) , RELM is in the intestine (8) , and RELM is expressed in hematopoietic tissues (9) . In humans, resistin and RELM homologous genes have been identified, with highest expression in macrophages (10, 11) and the intestine (8) , respectively.
RELMs encode peptides (105-117 amino acids) with 10 cysteine residues in the C-terminus having identical spacing (7, 12) . Resistin peptides are linked in pairs with disulfide bonds via the conserved cysteine residues and secreted as homodimers (13) .
Administration of recombinant resistin reduced insulin-mediated glucose uptake in 3T3-L1 adipocytes (6) as well as L6 rat skeletal muscle cells (14) . Resistin may also inhibit glucose oxidation and insulin-stimulated glycogenesis in isolated muscle from rats (15). Normally, insulin inhibits hepatic glucose production when plasma glucose levels rise in mice, but resistin attenuates this effect of insulin, promoting elevated plasma glucose concentration (16) 
Mice lacking resistin exhibit low blood glucose levels after fasting, due to reduced hepatic glucose production (17) . Transgenic expression of the mouse resistin gene in adipose tissue impaired oxidative and non-oxidative glucose disposal in skeletal muscle, and promoted glucose intolerance (15).
The resistin mRNA level was reduced by insulin sensitizing thiazolidinedione (TZD) ligands of the transcription factor peroxisome proliferator-activated receptor (PPAR) in 3T3-L1 adipocytes (6, 18, 19) , although the regulation in vivo has been disputed (6, 20, 21) . Both suppressors (insulin) and activators ( -adrenoceptor agonists) of lipolysis have been reported to reduce resistin mRNA levels in 3T3-L1 adipocytes (18, 22, 23) . Furthermore, intracellular
Haugen et al.
3 levels of cAMP (forskolin) involving protein kinase A may modulate the level of resistin mRNA (18, 23) .
Elevated plasma FFA is associated with insulin resistance (24) . However, dietary intake of PUFA may alter the development of human diseases such as cardiovascular diseases, diabetes and cancer, by affecting enzyme activities, cellular signal transduction and composition of membrane lipids (25) . In addition PUFA may influence gene expression by direct interaction with the transcription machinery (26) . Fatty acids may modulate the activity of adipogenic transcription factors PPAR , liver X receptor (LXR) and SREBP-1 (both SREBP-1a and -1c) (27) (28) (29) (30) .
Our aim of the present work was to study the effects of selected dietary FFAs on resistin expression in murine 3T3-L1 adipocytes to see if resistin could represent a link between elevated FFA plasma levels and insulin resistance. FFAs in general did not affect resistin mRNA levels. Only SA promoted a small increase in resistin expression, but we observed a marked suppression of resistin mRNA levels by AA and to a smaller extent by EPA. AA promoted its effects dependent on COX-1 and MEK activity. In transfection experiments SREBP-1a transactivated the resistin promoter, but we found no evidence that AA regulated SREBP-1 activity in 3T3-L1 adipocytes. Our data also suggested an active degradation of resistin mRNA dependent on de novo synthesis of mRNA and protein.
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Materials and Methods
Cell culture and supplements
3T3-L1 and COS-1 cells from American Type Culture Collection (ATCC; Rockville, MD)
were cultured in DMEM supplemented with 10 % fetal bovine serum (FBS) (Integro, Dieren, Holland), 2 mM L-glutamine, penicillin (50 units/mL), and streptomycin (50 µg/mL) at 37° C in 5 % CO 2 (31) . 3T3-L1 fibroblasts were seeded on 12-well plates and differentiation was initiated 2 days post-confluence (18) . After 6 days of differentiation, adipocytes were given fresh growth medium daily for up to 4 days, and every other day thereafter. The cells were either maintained for up to 8 days or 15 days after induction of differentiation, at which time specific treatments were initiated. Cells incubated under serum-free conditions were pretreated in DMEM containing 2 mM L-glutamin, streptomycin (50 µg/mL), penicillin (50 units/mL) and 1 % FFA-free BSA (Sigma) for 24 h. The sodium salt of the fatty acids palmitic acid (PA were disolved at 50 C to make 6 mM stock solutions in culture medium containing 2.4 mM FFA-free BSA (Sigma, St Louis, MO) and stored up to 1 month at -20 C under argon (32) .
Fatty acid containing media were dilutions of stock solutions and the molar ratio of BSA to 
RNA preparation and Northern blot/ RT-PCR analysis
Total RNA was prepared using the TRIzol method and RNA quality and quantity was determined spectrophotometrically. For Northern blots; RNA (10 g) was electrophoresed on 1.0 % agarose gel, containing 6.7 % formaldehyde, transferred onto Hybond-N nylon membranes (Amersham, Little Chalfont, UK) by capillary action and UV cross-linked (33).
Primer sequences for amplifying cDNA from the mouse resistin gene (approved name: Retn) (AGCGGATGAAGAACCTTTCA and GGAGGAGACTGTCCAGCAAT) were designed based on the available mRNA sequence (gi:12228705) using the Primer3 software (34) . Using 3T3-L1 mRNA as template, the 185 bp region of resistin cDNA was amplified on a Light
Cycler with the RNA Amplification Kit (Roche Diagnostics, GmbH, Mannheim, Germany).
The RT-PCR product was cloned and sequenced prior to hybridisation of membranes (33) .
Membranes were probed with [ -32 P]dCTP (Amersham)-radiolabeled cDNAs synthesised using multiple DNA labelling system (Amersham) and purified on ProbeQuant G50 Micro columns (Amersham) (33) . The tissue specificity of resistin mRNA detection using the probe described in this paper was the same as earlier (18 
Cloning of the mouse resistin promoter
The available resistin mRNA (gi:12228705) was used as a bait in a BLAST search against non The PCR amplitication was performed with Pfu Turbo DNA polymerase (Stratagene, La Jolla, CA) as described (31) 
Presentation of data and statistical analysis
Relative resistin mRNA levels were calculated as the ratio of resistin and 36B4 signal intensities. The effects of different incubations were expressed relative to the control incubation, which were assigned a value of 100 %, and presented in bars representing mean ± standard error of the mean (SE) of 3-5 experiments. The statistical significance of differences between incubations was assessed with two-tailed Student's t-test (*; P < 0.05, **; P < 0.01).
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Results
To test whether fatty acids affect the transcriptional level of resistin expression, we inhibited the AA-effect (33 ± 4 % of control; Figure 3A ). At concentrations > 50 M, LY294002 alone had an inhibitory effect on resistin expression (data not shown), and side effects of the inhibitor in combination with fatty acids cannot be excluded. Control incubations with OA in combination with the inhibitors did not affect resistin expression ( Figure 3A) .
Furthermore, the inhibitory effect of PGE 2 and PGF 2 on resistin expression was partially antagonized by the MEK inhibitor PD98059 ( Figure 3B ). This finding indicates that activation via the MAPK pathway is involved in AA-induced reduction of resistin mRNA expression, whereas signaling through the PI3K pathway seems less important.
As potential mediators of AA-regulated resistin expression, we investigated if the insulin-signaling pathway and activity of the nuclear receptors PPAR and LXR affect resistin expression. In the absence of serum, adipocytes differentiated for 15 days responded to insulin with a dose-dependent reduction in resistin mRNA ( Figure 4A , upper panels).
PD98059 reduced the effect of insulin on resistin expression ( Figure 4A , lower panels).
Contrary to our earlier experiments performed in the presence of serum (18) resistin promoter ( Figure 6A ). CCAAT/enhancer binding protein (C/EBP) has been shown to be a positive regulator of the resistin promoter (43, 44) , and we tested if the promoter region included in our constructs was able to convey activation by a C/EBP expression vector.
Transiently over-expressing C/EBP in COS-1 cells induced a 60-fold increase in relative LUC activity conferred by the -2610 to +720 bp resistin promoter ( Figure 6B ). With this reporter in COS-1 cells, PPAR 2 over-expression alone did not affect LUC activity, whereas together with darglitazone it induced a 2-fold increase ( Figure 6C ). In the same assay, cotransfection with the LXR expression plasmid alone or with T0901317, increased LUC activity 2-fold and 3-fold, respectively ( Figure 6C ). We tested the capacity of several adipocyte-enriched transcription factors to activate the resistin promoter in undifferentiated 3T3-L1 fibroblasts. Although to a much lesser extent than in COS-1, C/EBP over-expression also activated the -2610 to +720 bp resistin reporter construct in 3T3-L1 fibroblasts, resulting in a 3-fold increase in relative LUC activity ( Figure 6D ). When we over-expressed mature SREBP-1a in 3T3-L1 fibroblasts, we observed a > 12-fold increase in relative LUC activity with the -2610 to +720 bp resistin promoter construct ( Figure 6D ). Transfection with retinoic acid receptor (RXR) induced a small (3-fold) increase in relative LUC activity, and the effect of PPAR 2 or LXR in combination with RXR was only slightly inhibitory ( Figure 6D ).
Incubation of fibroblasts with AA or PGE 2 did not significantly affect the ability of C/EBP or SREBP-1a to induce the resistin reporter ( Figure 6D ). However, relative LUC-activity induced by SREBP-1a was reduced by approximately 50 % after incubation of the transfected fibroblasts with PGF 2 ( Figure 6D ). In undifferentiated 3T3-L1 fibroblasts, SREBP-1a activated the -2610/+720 and the -393 to +720 resistin constructs in a concentrationdependent manner, inducing up to a 12-fold increase in relative LUC activity for both constructs ( Figure 6E ).
We also examined other potential transcriptional and posttranscriptional processes in the AA-induced reductions in resistin mRNA. Incubation of adipocytes with AA did not change mRNA levels of LXR , SREBP-1 and PPAR ( Figure 7A ), suggesting that transcriptional regulation of these transcription factor genes is of minor importance for resistin expression.
SREBP-1 activity is also regulated at the posttranslational level, and cleavage of the SREBP-1 is required to release its mature and active form (45 hydroxycholesterol ( Figure 7B ). This does not show regulated SREBP-1 maturation in 3T3-L1 adipocytes, and does not support SREBP-1 maturation as an important factor in the AAregulated resistin expression. The effect of AA on resistin mRNA levels in adipocytes was abolished when the cells were incubated with cycloheximide or actinomycin D for 24 h ( Figure 7C) . Surprisingly, there was no reduction in the amount of resistin mRNA in the controls after incubation with actinomycin D for 24 h (Figure 7C ), whereas extending the incubation to 48 h resulted in a marked reduction of resistin mRNA in the controls ( Figure   7D ). The suppressive effect on resistin mRNA levels of both AA and T0901317 was more rapid than the effect of actinomycin D alone ( Figure 7D ).
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were required, whereas the EP2 agonist butaprost had no effect on resistin mRNA levels. The high dose of PGE 2 , sulprostone and misoprostol required to obtain an effect suggest that EP receptors are of small importance for regulation of resistin mRNA levels, and the effect may be indirect. However, the potent effect of PGF 2 (44) demonstrating that over-expression of PI3K suppressed resistin expression.
The transcription factors PPAR , LXR and SREBP-1 are induced during adipogenesis and their transcriptional activities may be regulated by PUFA. Previously we have shown that the PPAR agonist darglitazone reduced resistin mRNA in the presence of serum (18) . In our present study we observed that the down-regulatory effect of darglitazone was dependent on serum in the culture medium. Under these conditions we also observed that darglitazone neutralized the inhibiting effect of AA, suggesting an interaction between the two. We first suspected that AA could execute its effect on resistin via association to the PPAR ligand-
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binding pocket, and that darglitazone under these conditions functioned as a PPAR In conclusion, we observe that AA reduces resistin mRNA levels in 3T3-L1 adipocytes involving COX-1 and MEK activity, and possibly a destabilization of the resistin transcript.
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